Benign Essential Blepharospasm Research Foundation

What Benign Essential Blepharospasm Research Foundation does

The Benign Essential Blepharospasm Research Foundation (BEBRF) is a 501(c)(3) nonprofit research foundation founded in 1981 by Mattie Lou Koster and headquartered in Beaumont, Texas. It is the only organization solely dedicated to finding the cause, treatments, and cure for benign essential blepharospasm (BEB), a cranial and focal dystonia causing involuntary sustained muscle contractions and spasms of the eyelids, along with related disorders including Meige syndrome (oromandibular dystonia), hemifacial spasm, apraxia, and blepharitis. The organization is volunteer-run, not endowed, and receives no federal or local government funding, operating entirely on tax-deductible public and private charitable donations. Leadership is provided by Executive Director Charlene Hudgins and a Medical Advisory Board.

BEBRF delivers a portfolio of free patient support and educational services to a diffuse base of blepharospasm and Meige patients, caregivers, and medical professionals. The offering includes a national and international network of support groups (in-person in NYC and Dallas-Fort Worth, plus national Zoom meetings scheduled through 2026), an extensive educational content library (medical publications, articles, videos, medical glossary, FAQs, treatment guides covering botulinum toxin, oral medications, surgery, deep brain stimulation, and non-surgical aids), recurring webinars featuring medical experts, and an annual educational symposium recently hosted at Duke University (2024) and San Diego (2025). The foundation also operates a research funding program that channels donations into seed and partial grants via annual calls for proposals, and participates in the Dystonia Coalition Research program.

The business model is donation-driven with no pricing structure: every service is provided at no cost to patients or caregivers. There is no proprietary technology product, mobile app, or API; the technology footprint consists of the blepharospasm.org website, Facebook and YouTube channels, a free quarterly email newsletter, Zoom-based virtual programming, and webinar/symposium delivery infrastructure. Headcount is small (11-50), and the organization's credibility is supported by Candid Platinum transparency status, a Charity Navigator four-star rating, and a 2022 Great Non-Profits award.

Name

Benign Essential Blepharospasm Research Foundation

Legal name

Benign Essential Blepharospasm Research Foundation

Website

https://blepharospasm.org

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

11–50 employees

Short description

The Benign Essential Blepharospasm Research Foundation (BEBRF) is a 501(c)(3) nonprofit founded in 1981 that provides free patient support groups, education, and research funding for benign essential blepharospasm, Meige syndrome, and related facial movement disorders, serving patients, caregivers, and medical professionals.

Ownership category

akta.pro rank

Product category

Patient Advocacy and Disease Research Foundation

NAICS

Voluntary Health Organizations (813212), Grantmaking Foundations (813211)

SIC

Services-Social Services (8300), Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Private Foundations (BPAGAKAA), Chronic Disease & Health Promotion Program Funding (HLAJALAJ)

Keywords

• Patient support services
• Disease research funding
• Patient advocacy resources
• Medical support groups
• Nonprofit health foundation

Headquarters

HQ city

Beaumont

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: The BEBRF is a volunteer nonprofit organization that relies entirely on public and private charitable donations. It is not endowed or supported by federal or local governments. All donations are tax-deductible as the organization is an Exempt Organization under Section 501(c)(3) of the IRS.

Distribution channels3 records

Marketing channels7 records

Core offering

The foundation provides free patient support, peer-led support groups, patient and caregiver education (webinars, an annual symposium, printed materials), and grant funding for scientific research into the cause and treatment of benign essential blepharospasm, Meige syndrome, and related eyelid and facial movement disorders. Its primary beneficiaries are affected patients, their families/caregivers, and treating clinicians; its funding sources are charitable donations and sponsorships.

Product overview

The Benign Essential Blepharospasm Research Foundation (BEBRF) is a non-profit 501(c)(3) organization solely dedicated to finding the cause and cure for blepharospasm and Meige. BEBRF does not offer a technology product; rather, it provides a suite of patient support and education services including a network of support groups (both in-person and via Zoom), educational resources (publications, articles, videos, FAQs), webinars featuring medical experts, and an annual symposium. The organization's research funding program supports scientific investigation into causes, treatments, and cures for blepharospasm and related disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Support Groups Free, peer-led support groups for patients with benign essential blepharospasm and Meige syndrome, and their caregivers, delivered both virtually (via Zoom) and in person across the United States. Designed to reduce isolation, share coping strategies, and provide disease-specific community for a rare-disease population.
• Educational Webinars Online webinars hosted by the foundation to educate patients, caregivers, and clinicians on blepharospasm, Meige syndrome, treatment options (including botulinum toxin therapy), and coping strategies. Free of charge and aimed at a national audience.
• Annual Symposium / Conference Recurring annual symposium that brings together BEBRF patients, caregivers, clinicians, and researchers to share updates on research, treatment, and patient experience. Open to members of the patient community and the treating clinician/research community.
• Research Grant Funding Program Foundation-administered grant program that funds scientific research into the cause, treatment, and cure of benign essential blepharospasm, Meige syndrome, and related facial movement disorders. Targets academic clinicians and researchers working in ophthalmology, neurology, and movement disorders.
• Patient Information and Print Resources Printed educational materials, newsletters, and disease-information resources distributed to patients, caregivers, and clinicians, providing foundational information about benign essential blepharospasm and Meige syndrome that is otherwise difficult to find for this rare condition.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bachmann-Strauss Dystonia & Parkinson Foundation: Funds research and supports patients with dystonia (including blepharospasm) and Parkinson's disease. Closely comparable nonprofit structure, research grantmaking program, and patient education focus to BEBRF.
• CurePSP: Disease-specific nonprofit funding research and providing support for progressive supranuclear palsy (PSP) and related prime-of-life neurodegenerative disorders. Comparable in niche disease focus, donor-funded research model, and patient support services.
• Tourette Association of America: Patient advocacy and research funding nonprofit for Tourette Syndrome and related movement disorders. Comparable in disease-specific focus, support group network, research grantmaking, and donor-funded operating model.
• Dystonia Medical Research Foundation: Largest U.S. patient advocacy and research funding organization for all forms of dystonia, including blepharospasm and Meige. Directly comparable in mission, donor-funded model, support groups, and research grantmaking to BEBRF, though operating at a much larger scale and broader disease scope.

Emerging players

• Spastic Paraplegia Foundation: Small disease-specific nonprofit funding research and supporting patients with Hereditary Spastic Paraplegia. Comparable in niche disease scope, donor-funded research grants, and volunteer-led patient community model.

Regional players

• American Parkinson Disease Association: National nonprofit providing support, education, and research funding for Parkinson's disease and related movement disorders including blepharospasm. Comparable donor-funded nonprofit model and patient support infrastructure.

Broad incumbents

• National Organization for Rare Disorders (NORD): Umbrella advocacy and research organization for all rare diseases, including blepharospasm. Comparable in 501(c)(3) status, donor funding, and patient education/research focus, but operates as a broad incumbent across 7,000+ rare conditions rather than one.
• International Parkinson and Movement Disorder Society: Professional medical society covering all movement disorders including blepharospasm and dystonia. Provides medical education, research grants, and physician resources comparable to BEBRF's Medical Advisory Board functions, but as an incumbent clinical body.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCk929EkFpNAU8fQLTOErn0g
• Facebookfacebook.com/blepharospasm
• LinkedInlinkedin.com/company/benign-essential-blepharospasm

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Benign Essential Blepharospasm Research Foundation